GoodRx Holdings (GDRX) Shares Outstanding (Diluted Average) (2020 - 2026)

GoodRx Holdings' Shares Outstanding (Diluted Average) history runs 7 years deep, the most recent figure standing at $341.4 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) fell 10.07% year-over-year to $341.4 million; the TTM figure through Mar 2026 stood at $341.4 million (down 10.07% YoY), while the FY2025 annual figure was $357.0 million, down 8.98% from the prior year.
• Shares Outstanding (Diluted Average) came in at $341.4 million for Q1 2026 at GoodRx Holdings, down from $357.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $423.1 million in Q2 2022 to a low of $341.4 million in Q1 2026.
• A 5-year average of $392.2 million and a median of $392.9 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• Across the five-year window, Shares Outstanding (Diluted Average) climbed 0.85% in 2023 and decreased 10.07% in 2026, its largest moves.
• GoodRx Holdings' Shares Outstanding (Diluted Average) stood at $412.9 million in 2022, then slipped by 0.62% to $410.3 million in 2023, then retreated by 4.42% to $392.2 million in 2024, then dropped by 8.98% to $357.0 million in 2025, then declined by 4.36% to $341.4 million in 2026.
• According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $341.4 million, $357.0 million, and $361.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison